Halaven 1 mg/2mL
eribulin mesylate · INJECTION · BSP Pharmaceuticals SpA
Halaven (eribulin mesylate) is an intravenous injection used to treat certain types of cancer, including metastatic breast cancer and liposarcoma. It works by interfering with cell division to slow or stop the growth of cancer cells.
Key Facts
- Brand Name
- Halaven
- Generic Name
- eribulin mesylate
- NDC Code (Product)
43624-002- Manufacturer
- BSP Pharmaceuticals SpA
- Strength
- 1 mg/2mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA201532
- Marketing Start
- 04/21/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Halaven used for?
Halaven (eribulin mesylate) is an intravenous injection used to treat certain types of cancer, including metastatic breast cancer and liposarcoma. It works by interfering with cell division to slow or stop the growth of cancer cells.
Is Halaven a controlled substance?
Halaven is not classified as a controlled substance by the DEA.
What is the generic name for Halaven?
The generic name for Halaven is eribulin mesylate. There are 11 other brand versions of eribulin mesylate.
What is the NDC code for Halaven 1 mg/2mL?
The NDC (National Drug Code) for Halaven 1 mg/2mL is 43624-002, listed by BSP Pharmaceuticals SpA.
Other Eribulin Brands
See all →- ERIBULIN MESYLATE.5 mg/mL40033-364
- Eribulin Mesylate.5 mg/mL10019-080
- eribulin mesylate.5 mg/mL68083-592
- Eribulin Mesylate.5 mg/mL81298-3890
- Eribulin Mesylate.5 mg/mL0781-3391
- ERIBULIN MESYLATE.5 mg/mL0143-9167
- Eribulin Mesylate.5 mg/mL43598-125
- Eribulin Mesylate.5 mg/mL68001-656
- Eribulin Mesylate.5 mg/mL71731-4171
- ERIBULIN MESYLATE.5 mg/mL68462-770
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)